case
acut
pharyng
occur
colder
month
year
respiratori
virus
preval
spread
among
famili
member
home
promin
featur
epidemiolog
agent
children
provid
major
reservoir
ga
pharyng
primarili
diseas
children
year
age
temper
climat
preval
highest
winter
earli
spring
enterovir
pharyng
typic
occur
summer
earli
fall
gonococc
pharyng
occur
sexual
activ
adolesc
young
adult
usual
mode
infect
orogenit
sexual
contact
sexual
abus
must
consid
strongli
n
gonorrhoea
isol
pharynx
prepubert
child
widespread
immun
diphtheria
toxoid
made
diphtheria
rare
diseas
unit
state
fewer
case
report
annual
gc
gg
express
mani
toxin
ga
includ
streptolysin
gc
pharyng
clinic
featur
similar
ga
caus
elev
level
serum
antistreptolysin
aso
antibodi
gc
rel
common
caus
acut
pharyng
among
colleg
student
adult
seek
urgent
care
outbreak
gc
pharyng
relat
consumpt
contamin
food
product
eg
unpasteur
cow
milk
report
famili
school
although
also
sever
welldocu
foodborn
outbreak
gg
pharyng
role
gg
acut
endem
pharyng
remain
unclear
communitywid
outbreak
pharyng
among
children
describ
gg
isol
consecut
children
acut
pharyng
seen
privat
pediatr
offic
result
dna
fingerprint
suggest
isol
belong
gg
clone
role
gc
gg
acut
pharyng
may
underestim
mani
laboratori
report
gc
gg
even
organ
identifi
throat
cultur
laboratori
may
use
bacitracin
suscept
identifi
ga
mani
gc
gg
bacitracin
resist
rapid
antigen
detect
test
radt
recogn
cell
wall
carbohydr
ga
nonreact
carbohydr
gc
gg
certain
clinic
epidemiolog
find
suggest
ga
caus
acut
pharyng
box
patient
ga
pharyng
commonli
sore
throat
usual
sudden
onset
sever
pain
swallow
fever
also
headach
nausea
vomit
abdomin
pain
examin
typic
reveal
tonsillopharyng
erythema
without
exud
tender
enlarg
anterior
cervic
lymph
node
find
includ
beefi
red
swollen
uvula
petechia
palat
scarlatiniform
rash
find
specif
ga
fever
occur
peopl
lack
antitoxin
antibodi
although
less
common
clinic
less
sever
past
incid
scarlet
fever
cyclic
depend
preval
toxinproduc
strain
ga
immun
statu
popul
mode
transmiss
age
distribut
epidemiolog
featur
otherwis
similar
ga
pharyng
rash
scarlet
fever
appear
within
hour
onset
sign
symptom
first
sign
rash
often
begin
around
neck
spread
trunk
extrem
diffus
fine
papular
sandpaperlik
erythemat
erupt
produc
bright
red
discolor
skin
blanch
pressur
involv
often
intens
along
creas
antecubit
area
axilla
groin
petechia
occur
along
creas
ie
pastia
line
face
usual
spare
although
cheek
erythemat
pallor
around
mouth
fig
day
mani
patient
ga
pharyng
exhibit
sign
symptom
milder
classic
present
ill
bona
fide
ga
infect
ie
elev
titer
aso
antibodi
wherea
other
mere
colon
intercurr
viral
infect
ga
nasopharyng
infant
ie
streptococcosi
uncommon
difficult
differenti
viral
infect
ga
nasopharyng
caus
purul
nasal
discharg
excori
nare
infect
occur
without
pharyng
scarlet
fever
associ
characterist
rash
caus
ga
produc
pyrogen
exotoxin
ie
erythrogen
toxin
scarlet
part
ii
clinic
syndrom
cardin
featur
infecti
diseas
approach
diagnosi
initi
manag
rash
begin
fade
follow
fine
desquam
first
face
progress
downward
occasion
sheetlik
desquam
occur
around
fingernail
periungu
palm
sole
pharyng
find
ga
pharyng
tongu
usual
coat
papilla
swollen
desquam
redden
papilla
promin
give
tongu
strawberri
appear
substanti
overlap
find
scarlet
fever
kawasaki
diseas
lack
respons
antibiot
therapi
suspect
scarlet
fever
prompt
consider
kawasaki
diseas
clinic
find
conjunct
cough
hoars
coryza
anterior
stomat
discret
ulcer
lesion
viral
exanthema
myalgia
diarrhea
suggest
viru
rather
ga
caus
acut
pharyng
see
box
adenoviru
pharyng
typic
associ
fever
erythema
pharynx
enlarg
tonsil
exud
enlarg
cervic
lymph
node
adenovir
pharyng
associ
conjunct
refer
pharyngoconjunctiv
fever
adenoviru
pharyng
persist
day
conjunct
day
resolv
spontan
outbreak
pharyngoconjunctiv
fever
associ
transmiss
swim
pool
widespread
epidem
sporad
case
also
occur
enterovirus
ie
coxsackieviru
echoviru
enterovirus
associ
erythemat
pharyng
tonsillar
exud
cervic
lymphadenopathi
unusu
fever
promin
resolut
usual
occur
within
day
herpangina
specif
syndrom
caus
coxsackievirus
b
echovirus
character
fever
pain
discret
greywhit
papulovesicular
ulcer
lesion
erythemat
base
posterior
oropharynx
fig
handfootandmouth
diseas
character
pain
vesicl
ulcer
throughout
oropharynx
associ
vesicl
palm
sole
sometim
trunk
extrem
enterovir
lesion
usual
resolv
within
day
primari
oral
hsv
infect
usual
occur
young
children
typic
produc
acut
gingivostomat
associ
ulcer
vesicular
lesion
throughout
anterior
mouth
lip
spare
posterior
pharynx
hsv
gingivostomat
last
week
often
associ
high
fever
pain
intens
poor
oral
intak
lead
dehydr
adolesc
adult
hsv
also
caus
mild
pharyng
may
may
associ
typic
vesicular
ulcer
lesion
ebv
pharyng
infecti
mononucleosi
sever
oral
clinic
find
ident
ga
pharyng
fig
gener
lymphadenopathi
hepatosplenomegali
also
occur
posterior
cervic
lymphadenopathi
prestern
periorbit
haemolyticum
pharyng
resembl
ga
pharyng
includ
scarlatiniform
rash
rare
haemolyticum
produc
membran
pharyng
confus
diphtheria
pharyng
diphtheria
character
greyish
brown
pseudomembran
limit
one
tonsil
extend
wide
involv
nare
uvula
soft
palat
pharynx
larynx
tracheobronchi
tree
involv
tracheobronchi
tree
lead
lifethreaten
respiratori
obstruct
soft
tissu
edema
promin
cervic
subment
lymphadenopathi
caus
bullneck
appear
f
necrophorum
caus
pharyng
adolesc
young
adult
f
necrophorum
appear
caus
typic
sign
bacteri
pharyng
ie
high
fever
odynophagia
lymphadenopathi
exud
tonsil
caus
concomit
bacteremia
frequenc
progress
tonsil
lemierr
syndrom
unknown
hour
although
initi
therapeut
decis
guid
neg
result
hour
advis
wait
hour
definit
result
clinic
signific
number
coloni
ga
grow
inocul
agar
controversi
although
densiti
bacteria
like
greater
patient
bona
fide
acut
ga
pharyng
ga
carrier
much
overlap
coloni
count
permit
differenti
basi
coloni
densiti
bacitracin
disk
test
wide
use
direct
microbiolog
method
differenti
ga
streptococci
use
growth
sheep
blood
agar
presumpt
identif
base
observ
ga
demonstr
zone
inhibit
around
disk
contain
unit
bacitracin
wherea
nonga
inhibit
bacitracin
altern
highli
specif
method
differenti
streptococci
commerci
avail
groupspecif
cell
wall
carbohydr
antigen
detect
test
appli
directli
isol
coloni
addit
expens
minim
improv
accuraci
may
justifi
radt
develop
identif
ga
directli
throat
swab
expens
blood
agar
cultur
offer
speed
provid
result
rapid
identif
treatment
patient
ga
pharyng
reduc
risk
spread
ga
speed
clinic
improv
allow
patient
return
school
work
sooner
certain
environ
eg
emerg
depart
use
radt
compar
throat
cultur
significantli
increas
number
patient
appropri
treat
ga
pharyng
radt
specif
higher
compar
blood
agar
cultur
therapeut
decis
made
confid
basi
posit
radt
result
howev
sensit
radt
two
larg
metaanalys
pool
patient
conclud
modern
radt
sensit
children
although
patient
posit
radt
result
mere
ga
carrier
larg
proport
infect
ga
first
radt
use
latex
agglutin
methodolog
rel
insensit
unclear
end
point
subsequ
test
base
enzym
immunoassay
techniqu
sharpli
defin
end
point
increas
sensit
radt
use
optic
immunoassay
oia
bead
concentr
antigen
fluoresc
detect
chemiluminesc
dna
probe
may
sensit
radt
perhap
sensit
blood
agar
plate
cultur
rapid
detect
done
radt
margin
sensit
advisori
group
still
recommend
confirmatori
blood
agar
cultur
children
adolesc
suspect
clinic
ground
ga
pharyng
neg
radt
result
higher
sensit
radt
adult
children
idsa
allow
exclus
ga
pharyng
base
neg
radt
result
alon
although
physician
may
continu
use
throat
cultur
achiev
maxim
sensit
although
nucleic
acid
detect
superior
sensit
compar
radt
sensit
similar
cultur
circumst
clinic
result
may
faster
cultur
although
faster
technolog
becom
avail
nucleic
acid
detect
minut
pointofcar
test
high
cost
new
technolog
may
limit
practic
use
primari
care
set
cultur
radt
nucleic
acid
amplif
test
accur
differenti
individu
ga
pharyng
carrier
howev
definit
test
facilit
nontreat
patient
ie
without
ga
estim
million
provid
visit
sore
throat
occur
year
unit
state
antimicrobi
therapi
histor
prescrib
visit
educ
reduc
prescript
antibiot
children
adolesc
pharyng
one
studi
document
overal
decreas
prescript
children
pharyng
although
decreas
penicillin
prescript
offset
increas
macrolid
prescript
distinguish
ga
viral
pharyng
key
manag
us
practic
score
system
incorpor
clinic
epidemiolog
featur
attempt
predict
probabl
ill
caus
ga
clinic
score
system
best
aim
identifi
individu
low
risk
ga
infect
throat
cultur
radt
usual
unnecessari
systemat
review
articl
individu
symptom
sign
pharyng
assess
articl
data
predict
rule
individu
combin
symptom
sign
allow
format
guidelin
could
use
diagnos
ga
pharyng
probabl
higher
similarli
review
found
rang
probabl
guidelin
infecti
diseas
societi
america
idsa
american
academi
pediatr
aap
american
heart
associ
aha
requir
microbiolog
confirm
throat
cultur
radt
diagnosi
ga
pharyng
decis
perform
microbiolog
test
child
adolesc
acut
pharyng
base
clinic
epidemiolog
characterist
ill
see
box
histori
close
contact
document
case
ga
pharyng
high
preval
ga
commun
also
help
select
use
diagnost
studi
ga
increas
proport
posit
test
result
test
posit
predict
valu
ie
percentag
patient
posit
test
infect
rather
mere
colon
ga
adult
infrequ
infect
ga
rare
develop
rheumat
fever
center
diseas
control
prevent
cdc
american
academi
famili
physician
aafp
american
colleg
physician
american
societi
intern
medicin
acpasim
recommend
use
clinic
algorithm
without
microbiolog
confirm
accept
approach
diagnosi
ga
pharyng
adult
although
goal
algorithmbas
strategi
reduc
inappropri
use
antibiot
studi
intend
assess
impact
six
differ
guidelin
identif
treatment
ga
pharyng
children
adult
found
select
use
radt
without
throat
cultur
treatment
base
posit
test
result
significantli
reduc
inappropri
use
antibiot
adult
contrast
empir
strategi
propos
cdc
aafp
acpasim
guidelin
result
administr
unnecessari
antibiot
unaccept
larg
number
adult
diagnosi
adult
symptom
complex
therefor
discourag
latest
aha
scientif
statement
acpasim
guidelin
inactiv
cdc
recommend
diagnost
test
adult
symptom
consist
ga
pharyng
throat
cultur
cultur
sheep
blood
agar
specimen
obtain
throat
swab
standard
laboratori
procedur
microbiolog
confirm
ga
pharyng
perform
correctli
throat
cultur
sensit
neg
result
occur
patient
receiv
antibiot
sampl
sever
variabl
affect
accuraci
throat
cultur
result
one
import
manner
specimen
obtain
surfac
tonsil
tonsillar
fossa
posterior
pharyng
wall
swab
area
pharynx
mouth
eg
anterior
mucosa
tongu
saliva
accept
sampl
site
touch
procedur
anaerob
incub
use
select
cultur
media
increas
sensit
throat
cultur
ga
recoveri
howev
data
regard
impact
atmospher
incub
cultur
media
conflict
absenc
definit
benefit
increas
cost
effort
associ
anaerob
incub
select
cultur
media
difficult
justifi
durat
incub
impact
yield
throat
cultur
cultur
incub
least
hour
read
addit
overnight
incub
room
temperatur
howev
identifi
substanti
posit
cultur
studi
patient
pharyng
neg
radt
result
posit
ga
cultur
neg
hour
incub
posit
part
ii
clinic
syndrom
cardin
featur
infecti
diseas
approach
diagnosi
initi
manag
prospect
studi
clarifi
issu
beyond
doubt
erad
carrier
state
confound
mani
studi
although
use
cephalosporin
ga
pharyng
could
reduc
number
peopl
especi
chronic
carrier
harbor
ga
complet
therapi
empir
firstlin
use
would
associ
substanti
econom
cost
risk
increas
antimicrobi
resist
without
substanti
benefit
compel
reason
eg
narrow
antimicrobi
spectrum
low
cost
impress
safeti
profil
continu
use
penicillin
drug
choic
uncompl
ga
pharyng
oral
penicillin
must
administ
mani
time
day
day
achiev
maxim
rate
ga
erad
attempt
treat
ga
pharyng
singl
daili
dose
penicillin
unsuccess
reduc
frequenc
dose
shorter
treatment
cours
day
may
result
better
patient
adher
therapi
sever
antimicrobi
agent
includ
clarithromycin
cefuroxim
cefixim
ceftibuten
cefdinir
cefpodoxim
effect
ga
erad
administ
day
less
effect
erad
oncedaili
dose
describ
amoxicillin
azithromycin
cefadroxil
cefixim
ceftibuten
cefpodoxim
cefprozil
cefdinir
howev
end
point
studi
typic
erad
ga
symptomat
improv
prevent
rheumat
fever
two
main
clinic
reason
treatment
mani
agent
broader
spectrum
activ
even
administ
short
cours
expens
standard
therapi
addit
studi
need
shortcours
oncedaili
dose
regimen
recommend
routin
penicillin
tabl
give
recommend
sever
regimen
proven
efficaci
ga
pharyng
intramuscular
benzathin
penicillin
g
prefer
patient
unlik
complet
full
cours
oral
therapi
although
ga
resist
penicillin
occur
anywher
world
geograph
area
rel
high
level
resist
macrolid
antibiot
averag
macrolid
resist
us
multicent
studi
rang
prospect
multicent
us
communitybas
surveil
studi
pharyng
ga
asymptomat
peopl
posit
throat
cultur
radt
result
complet
cours
appropri
antimicrobi
therapi
ga
pharyng
ga
carrier
routin
followup
test
indic
followup
throat
cultur
radt
asymptomat
individu
perform
histori
rheumat
fever
consid
patient
develop
acut
pharyng
outbreak
acut
rheumat
fever
poststreptococc
acut
glomerulonephr
individu
close
semiclos
commun
outbreak
ga
pharyng
antistreptococc
antibodi
titer
valu
diagnosi
acut
ga
pharyng
use
prospect
epidemiolog
studi
differenti
true
ga
infect
ga
carriag
antistreptococc
antibodi
valuabl
confirm
prior
ga
infect
patient
suspect
acut
rheumat
fever
nonsuppur
complic
need
definit
diagnos
nonga
caus
pharyng
occur
rare
usual
ill
prolong
symptom
haemolyticum
identifi
use
standard
cultur
method
intend
identifi
ga
requir
use
standard
respiratori
cultur
method
n
gonorrhoea
identifi
use
select
agar
growth
media
nucleic
acid
amplif
test
ebv
routin
diagnos
use
heterophil
antibodi
ie
monospot
low
sensit
younger
children
necessit
use
specif
antibodi
test
serum
pcr
method
common
virus
hsv
adenovirus
enterovirus
identifi
gener
viral
cultur
pcr
pursuit
diagnosi
f
necrophorum
pharyng
controversi
isol
anaerob
requir
special
laboratori
techniqu
detect
requir
use
molecular
techniqu
data
treatment
f
necrophorum
pharyng
hasten
symptomat
relief
prevent
lemierr
diseas
antimicrobi
therapi
indic
individu
symptomat
pharyng
ga
confirm
radt
cultur
clinic
epidemiolog
find
strongli
suggest
ga
antimicrobi
therapi
initi
await
microbiolog
confirm
provid
therapi
discontinu
radt
result
cultur
neg
antimicrobi
therapi
ga
pharyng
shorten
clinic
cours
ill
howev
ga
pharyng
usual
selflimit
sign
symptom
resolv
spontan
within
day
onset
initi
antimicrobi
therapi
delay
day
onset
ga
pharyng
still
prevent
occurr
acut
rheumat
fever
penicillin
congen
eg
ampicillin
amoxicillin
numer
cephalosporin
macrolid
clindamycin
effect
treatment
ga
pharyng
sever
advisori
group
recommend
penicillin
treatment
choic
ga
remain
exquisit
suscept
agent
decad
amoxicillin
often
use
accept
tast
suspens
although
efficaci
appear
equal
penicillin
oral
administ
clarithromycin
azithromycin
also
effect
discuss
later
sulfa
drug
includ
trimethoprimsulfamethoxazol
tetracyclin
effect
use
treat
ga
pharyng
basi
metaanalysi
clinic
trial
complet
cephalosporin
compar
penicillin
treatment
ga
tonsillopharyng
author
conclud
cephalosporin
treatment
choic
ga
tonsillopharyng
howev
sever
methodolog
flaw
notabl
inclus
ga
carrier
led
controversi
regard
conclus
indirect
evid
superior
cephalosporin
penicillin
prevent
treatment
failur
relaps
continu
appear
winter
spring
temper
climat
mani
asymptomat
schoolag
children
carri
ga
ga
carrier
sought
given
antimicrobi
therapi
primari
approach
suspect
confirm
carrier
reassur
throat
cultur
radt
perform
patient
symptom
sign
suggest
ga
pharyng
avoid
symptom
typic
viral
ill
see
box
clinic
episod
confirm
posit
cultur
radt
treat
identif
erad
streptococc
carrier
state
desir
rare
specif
situat
antimicrobi
therapi
employ
oral
clindamycin
mgkgday
mg
divid
dose
day
prefer
intramuscular
benzathin
penicillin
alon
combin
procain
penicillin
plu
oral
rifampin
mgkgday
divid
dose
maximum
dose
mg
day
begin
day
penicillin
inject
also
effect
chronic
carriag
recur
reexposur
ga
patient
symptom
suggest
ga
treatment
throat
cultur
radt
usual
perform
result
posit
mani
clinician
elect
administ
second
cours
penicillin
therapi
patient
repeat
episod
acut
pharyng
associ
posit
throat
cultur
radt
result
common
difficult
problem
practic
physician
fundament
question
whether
patient
experienc
repeat
episod
ga
pharyng
ga
carrier
experienc
repeat
episod
viral
pharyng
latter
situat
far
common
patient
like
ga
carrier
clinic
epidemiolog
find
suggest
viral
caus
littl
clinic
respons
appropri
antimicrobi
therapi
throat
cultur
radt
result
posit
episod
pharyng
serolog
respons
ga
extracellular
antigen
eg
aso
antideoxyribonucleas
b
contrast
patient
repeat
episod
acut
pharyng
associ
posit
throat
cultur
radt
result
like
experienc
repeat
episod
ga
pharyng
clinic
epidemiolog
find
suggest
ga
pharyng
demonstr
clinic
respons
appropri
antimicrobi
therapi
throat
cultur
radt
result
neg
episod
pharyng
serolog
respons
ga
extracellular
antigen
determin
patient
experienc
repeat
episod
true
ga
pharyng
physician
suggest
use
oral
penicillin
v
prophylact
howev
efficaci
regimen
prove
antimicrobi
prophylaxi
recommend
except
prevent
recurr
rheumat
fever
patient
experienc
previou
episod
rheumat
fever
tonsillectomi
may
consid
rare
patient
whose
symptomat
episod
diminish
frequenc
time
altern
explan
recurr
ga
pharyng
evid
howev
tonsillectomi
benefici
rel
small
group
patient
benefit
rel
short
live
cochran
review
found
children
tonsillectomi
episod
sore
throat
first
year
surgeri
compar
episod
per
year
tonsillectomi
children
sever
frequent
episod
receiv
largest
benefit
ga
pharyng
associ
suppur
nonsuppur
complic
see
chapter
suppur
complic
result
spread
ga
adjac
structur
includ
peritonsillar
abscess
parapharyng
retropharyng
abscess
cervic
lymphaden
sinus
otiti
media
mastoid
antimicrobi
agent
avail
suppur
complic
ga
pharyng
common
antimicrobi
therapi
greatli
reduc
frequenc
complic
refer
avail
onlin
wwwexpertconsultcom
isol
recov
children
year
age
three
success
respiratori
season
found
macrolid
resist
less
clindamycin
resist
found
evid
increas
erythromycin
minimum
inhibitori
concentr
studi
period
howev
consider
geograph
variat
macrolid
resist
rate
studi
year
yeartoyear
variat
individu
studi
site
higher
resist
rate
report
occasion
exampl
pharyng
invas
ga
strain
collect
san
francisco
studi
macrolid
resist
longitudin
investig
ga
diseas
singl
elementari
school
pittsburgh
investig
found
isol
ga
collect
resist
erythromycin
none
resist
clindamycin
molecular
type
indic
outbreak
caus
singl
strain
ga
clinician
awar
local
rate
resist
risk
chang
short
period
evid
control
studi
guid
therapi
acut
pharyng
group
c
group
g
streptococci
isol
physician
elect
treat
regimen
similar
ga
pharyng
penicillin
antimicrobi
agent
choic
acyclovir
treatment
hsv
gingivostomat
initi
within
hour
onset
symptom
shorten
durat
ill
although
use
antivir
medic
primari
ebv
pharyng
interrupt
viral
replic
temporarili
symptomat
relief
neglig
justifi
use
acyclovir
corticosteroid
recommend
ebv
pharyng
tonsillar
enlarg
threaten
airway
patenc
system
diseas
myocard
massiv
splenomegali
sever
review
includ
cochran
review
heterogen
studi
use
corticosteroid
ga
nonga
pharyng
found
small
measur
benefit
pain
reduct
especi
initi
earli
cours
sever
ill
howev
increas
deep
neck
infect
tempor
associ
increas
use
antiinflammatori
medic
includ
corticosteroid
pharyng
modest
shortliv
benefit
treatment
must
weigh
potenti
harm
use
corticosteroid
pharyng
recommend
aap
idsa
antimicrobi
treatment
failur
ga
pharyng
classifi
clinic
bacteriolog
failur
signific
clinic
treatment
failur
ie
persist
recurr
sign
symptom
suggest
ga
pharyng
difficult
determin
without
repeat
isol
infect
strain
ga
ie
true
bacteriolog
treatment
failur
bacteriolog
treatment
failur
classifi
true
appar
true
bacteriolog
failur
refer
inabl
erad
specif
strain
ga
caus
acut
episod
pharyng
complet
cours
appropri
antimicrobi
therapi
absenc
penicillin
resist
follow
factor
suggest
establish
definit
caus
penicillin
toler
ie
discord
concentr
penicillin
requir
inhibit
kill
organ
enhanc
colon
growth
ga
pharyng
flora
inactiv
penicillin
product
resist
intracellular
organ
antimicrobi
kill
appar
bacteriolog
failur
occur
newli
acquir
ga
isol
mistaken
origin
infect
strain
infect
strain
ga
erad
rapidli
reacquir
adher
antimicrobi
therapi
poor
howev
bacteriolog
treatment
failur
manifest
ga
carrier
state
chronic
carrier
clinic
ill
immunolog
respons
organ
colon
month
longer
unlik
spread
ga
close
contact
low
risk
develop
suppur
nonsuppur
complic
